tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Lepu Biopharma Co. Ltd. Class H (2157) Ratios

Compare
2 Followers

Lepu Biopharma Co. Ltd. Class H Ratios

HK:2157's free cash flow for Q4 2024 was ¥0.77. For the 2024 fiscal year, HK:2157's free cash flow was decreased by ¥ and operating cash flow was ¥-0.90. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.96 0.75 0.96 0.57 2.21
Quick Ratio
0.93 0.72 0.93 0.53 2.16
Cash Ratio
0.79 0.47 0.79 0.28 1.05
Solvency Ratio
-0.36 0.05 -0.36 -0.76 -0.56
Operating Cash Flow Ratio
-0.57 -0.28 -0.57 -1.13 -1.11
Short-Term Operating Cash Flow Coverage
-1.34 -0.58 -1.34 -10.29 0.00
Net Current Asset Value
¥ -815.61M¥ -818.46M¥ -815.61M¥ -920.85M¥ -78.54M
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.31 0.27 0.16 0.08
Debt-to-Equity Ratio
0.77 0.83 0.77 0.40 0.14
Debt-to-Capital Ratio
0.43 0.45 0.43 0.29 0.12
Long-Term Debt-to-Capital Ratio
0.24 0.22 0.24 0.22 0.09
Financial Leverage Ratio
2.81 2.66 2.81 2.49 1.64
Debt Service Coverage Ratio
-1.80 0.19 -1.80 -14.21 -4.75
Interest Coverage Ratio
-94.35 0.33 -94.35 -374.49 -6.11
Debt to Market Cap
0.06 0.11 0.06 0.03 0.01
Interest Debt Per Share
0.43 0.46 0.43 0.20 0.17
Net Debt to EBITDA
-0.04 3.69 -0.04 -0.21 0.54
Profitability Margins
Gross Profit Margin
87.12%87.45%87.12%0.00%0.00%
EBIT Margin
-4443.71%-6.93%-4443.71%0.00%0.00%
EBITDA Margin
-3830.77%38.58%-3830.77%0.00%0.00%
Operating Profit Margin
-4524.03%2.13%-4524.03%0.00%0.00%
Pretax Profit Margin
-4491.66%-13.45%-4491.66%0.00%0.00%
Net Profit Margin
-4424.94%-9.81%-4424.94%0.00%0.00%
Continuous Operations Profit Margin
-4491.66%-13.45%-4491.66%0.00%0.00%
Net Income Per EBT
98.51%72.92%98.51%98.26%94.85%
EBT Per EBIT
99.28%-631.80%99.28%101.90%117.89%
Return on Assets (ROA)
-27.24%-0.93%-27.24%-48.56%-24.01%
Return on Equity (ROE)
-76.50%-2.46%-76.50%-120.83%-39.49%
Return on Capital Employed (ROCE)
-41.80%0.32%-41.80%-65.86%-25.49%
Return on Invested Capital (ROIC)
-37.00%0.25%-37.00%-64.36%-26.60%
Return on Tangible Assets
-34.93%-1.13%-34.93%-67.62%-32.19%
Earnings Yield
-6.47%-0.35%-6.47%-10.48%-5.84%
Efficiency Ratios
Receivables Turnover
5.12 5.96 5.12 0.00 0.00
Payables Turnover
0.01 0.14 0.01 0.00 0.00
Inventory Turnover
0.08 0.96 0.08 0.00 0.00
Fixed Asset Turnover
0.02 0.21 0.02 0.00 0.00
Asset Turnover
<0.01 0.09 <0.01 0.00 0.00
Working Capital Turnover Ratio
-0.12 -1.78 -0.12 0.00 0.00
Cash Conversion Cycle
-25.79K -2.24K -25.79K 0.00 0.00
Days of Sales Outstanding
71.26 61.23 71.26 0.00 0.00
Days of Inventory Outstanding
4.38K 379.65 4.38K 0.00 0.00
Days of Payables Outstanding
30.24K 2.68K 30.24K 0.00 0.00
Operating Cycle
4.45K 440.88 4.45K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.29 -0.15 -0.29 -0.37 -0.25
Free Cash Flow Per Share
-0.36 -0.18 -0.36 -0.50 -0.44
CapEx Per Share
0.07 0.02 0.07 0.13 0.18
Free Cash Flow to Operating Cash Flow
1.23 1.16 1.23 1.34 1.71
Dividend Paid and CapEx Coverage Ratio
-4.35 -6.09 -4.35 -2.91 -1.40
Capital Expenditure Coverage Ratio
-4.35 -6.09 -4.35 -2.91 -1.40
Operating Cash Flow Coverage Ratio
-0.70 -0.34 -0.70 -1.85 -2.08
Operating Cash Flow to Sales Ratio
-30.88 -1.11 -30.88 0.00 0.00
Free Cash Flow Yield
-5.55%-4.61%-5.55%-8.66%-7.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-15.45 -286.50 -15.45 -9.54 -17.12
Price-to-Sales (P/S) Ratio
683.76 28.09 683.76 0.00 0.00
Price-to-Book (P/B) Ratio
11.82 7.06 11.82 11.53 6.76
Price-to-Free Cash Flow (P/FCF) Ratio
-18.00 -21.68 -18.00 -11.55 -13.75
Price-to-Operating Cash Flow Ratio
-22.14 -25.24 -22.14 -15.51 -23.57
Price-to-Earnings Growth (PEG) Ratio
0.50 2.96 0.50 -0.13 -0.58
Price-to-Fair Value
11.82 7.06 11.82 11.53 6.76
Enterprise Value Multiple
-17.88 76.50 -17.88 -11.35 -26.31
Enterprise Value
10.67B 6.65B 10.67B 9.82B 9.76B
EV to EBITDA
-17.88 76.50 -17.88 -11.35 -26.31
EV to Sales
685.11 29.51 685.11 0.00 0.00
EV to Free Cash Flow
-18.04 -22.78 -18.04 -11.76 -13.48
EV to Operating Cash Flow
-22.18 -26.52 -22.18 -15.80 -23.10
Tangible Book Value Per Share
0.21 0.27 0.21 0.16 0.53
Shareholders’ Equity Per Share
0.55 0.54 0.55 0.50 0.89
Tax and Other Ratios
Effective Tax Rate
-0.09 0.00 -0.09 -0.03 -0.05
Revenue Per Share
<0.01 0.14 <0.01 0.00 0.00
Net Income Per Share
-0.42 -0.01 -0.42 -0.61 -0.35
Tax Burden
0.99 0.73 0.99 0.98 0.95
Interest Burden
1.01 1.94 1.01 1.00 1.16
Research & Development to Revenue
33.67 2.03 33.67 0.00 0.00
SG&A to Revenue
8.92 0.38 8.92 0.00 0.00
Stock-Based Compensation to Revenue
1.95 0.08 1.95 0.00 0.00
Income Quality
0.69 11.35 0.69 0.60 0.69
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis